Apple Stock Soars on Broadcom Deal. Here's What You Need to Know.
By Maksym Misichenko · Nasdaq ·
By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel generally agreed that Apple's Broadcom deal secures supply stability and mitigates risk, but the market's 4% reaction may be overstated, and the long-term contract could create pricing leverage for Broadcom. The AI narrative and potential revenue uplift remain unproven.
Risk: Margin compression due to elevated memory costs and dependence on Broadcom's pricing leverage.
Opportunity: Supply stability and insurance against potential future export controls on advanced semiconductor manufacturing.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The market was abuzz this week with news that Apple (NASDAQ: AAPL) and Broadcom (NASDAQ: AVGO) renewed a deal for Apple to buy chips from Broadcom. While that's a clear win for Broadcom, Apple stock soared more than 4% in one day on the news, too. Here's what you need to know.
There weren't many details about the deal, which was announced in a Broadcom regulatory filing. This was the entire note: "Broadcom and Apple have agreed to expand their long-standing technology collaboration through 2031 by entering into new multi-year long-term agreements for Broadcom to develop and supply a range of custom ASIC silicon products for use in multiple generations of Apple products."
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
The two companies have been collaborating for many years. At least as far back as 2019, Broadcom provided radio-frequency units to Apple, well before artificial intelligence (AI) was on the radar as a growth driver for semiconductor companies. In 2020, Apple and Broadcom inked a three-year deal for Broadcom to supply wireless components as Apple entered the 5G market, a business Broadcom was then focused on. Even then, Apple was looking into designing its own chips, and the deal was a reassurance for Broadcom, since Apple represented about 20% of its business at the time.
The deal was renewed in 2023 as Apple expanded its 5G launch and was part of a $430 billion commitment made to invest in U.S. companies over five years.
The new deal is for a much longer period and is further reassurance for Broadcom shareholders that the company isn't losing one of its biggest clients.
But Apple investors think it's a great update, too. It implies that Apple is investing in Apple Intelligence, which is still in launch mode, and preparing for upgraded products and "multiple generations" throughout its enterprise.
It also secures Apple's commitment from Broadcom, whose ASICs, or application-specific integrated circuits, have become more valuable to tech companies because they're cheaper and faster for specific tasks. Broadcom's history as a connectivity and network component company, along with its newer chips that power AI, fits Apple's product lines like a glove. This is most pronounced for the iPhone, Apple's premier product, which accounts for about half of its total sales.
The announcement comes on the heels of Apple raising prices on many of its products due to skyrocketing memory costs, and the longer-term deal brings stability and may keep prices steadier.
Before you buy stock in Apple, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Apple wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $407,004! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,244,599!
Now, it’s worth noting Stock Advisor’s total average return is 924% — a market-crushing outperformance compared to 210% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of July 10, 2026. *
Jennifer Saibil has positions in Apple. The Motley Fool has positions in and recommends Apple and Broadcom. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The market is misinterpreting a defensive supply chain stabilization move as a catalyst for accelerated AI-driven growth."
The market's 4% reaction to this renewal is a classic case of 'certainty premium' being priced into AAPL. While the article frames this as an AI-driven win, it is fundamentally a defensive supply chain hedge. By locking in AVGO through 2031, Apple secures high-margin custom ASIC capacity, mitigating the risk of component shortages as they scale Apple Intelligence. However, the market is conflating 'supply stability' with 'innovation acceleration.' Apple is paying a premium for reliability, not necessarily breakthrough tech. At current valuations, investors are ignoring the margin compression risk if memory costs remain elevated and Apple fails to pass those costs to consumers in a saturated smartphone market.
The deal could signal that Apple has hit a wall in its internal silicon design efforts, forcing a long-term, expensive reliance on third-party vendors rather than achieving the vertical integration that historically drove their margin expansion.
"AVGO got a meaningful revenue lock; AAPL's 4% move rests on inference, not disclosed facts, and conflates a component supply deal with validation of Apple's AI strategy."
The article conflates two separate stories. Yes, AVGO gets a revenue floor through 2031—material for AVGO shareholders. But AAPL's 4% pop on a vague 'custom ASIC' renewal is harder to justify. The article implies this signals Apple Intelligence momentum, but the filing reveals almost nothing about volumes, pricing, or which products. ASICs are table-stakes for any major tech company; Broadcom's involvement doesn't validate Apple's AI strategy or justify re-rating. The price hike commentary is buried—Apple raising prices due to memory costs is margin-positive short-term but demand-destructive long-term. The article also omits that Apple has been designing its own chips since M1; why does a Broadcom connectivity deal suddenly prove Apple's committed to multiple product generations?
A 7-year deal with explicit multi-generation language *is* rare and does signal confidence in product roadmap continuity—if Broadcom wouldn't commit unless Apple showed real pipeline visibility, this could be a legitimate forward-looking signal that got priced in.
"N/A"
[Unavailable]
"Long-term value hinges on Apple Intelligence execution and potential shifts in Broadcom pricing or supplier strategy, not merely the existence of a 2031 supply contract."
Apple's Broadcom deal through 2031 signals supply stability for AI-enabled devices and multi-generation products, a reassuring backdrop as margins hinge on hardware costs. But the article glosses over big caveats: Apple is aggressively expanding in-house silicon and could broaden supplier diversification, reducing Broadcom's long-run leverage; the long-term contract creates optionality on pricing and profitability if Broadcom raises costs or memory-driven price pressures pass through more slowly than expected; and a broad AI narrative remains unproven in terms of actual revenue uplift. The initial stock move looks like a relief rally rather than a durable re-rating; execution risk around Apple Intelligence matters most.
Alternative view: If Apple accelerates in-house silicon and shifts more design work in-house or to other suppliers, Broadcom revenue from Apple could plateau, making the 2031 deal less meaningful than it appears.
"The Broadcom deal is a defensive geopolitical hedge against supply chain fragmentation rather than an AI-driven innovation play."
Claude, you’re missing the geopolitical reality. This isn't just about 'table-stakes' ASICs; it’s about securing TSMC-adjacent capacity in a world where trade restrictions could choke off high-end silicon. By locking Broadcom into a 2031 horizon, Apple is effectively buying an insurance policy against supply chain bifurcation. The market isn't pricing in 'innovation'; it's pricing in the survival of Apple's premium hardware ecosystem against potential future export controls on advanced semiconductor manufacturing.
"The deal is a pricing hedge, not a geopolitical supply chain insurance policy—an important distinction for valuation."
Gemini's geopolitical framing is compelling but overstated. TSMC capacity isn't the constraint here—Broadcom *designs* ASICs; TSMC manufactures them. Apple already has TSMC allocation priority. The real insurance is against Broadcom raising prices mid-contract or shifting capacity to competitors. A 2031 lock-in protects Apple's cost structure, not manufacturing access. That's valuable but narrower than a 'survival policy' against export controls.
[Unavailable]
"The 2031 Broadcom deal is not an existential hedge against export controls; it's a price/margin risk anchor that could limit Apple’s flexibility if Broadcom raises prices or shifts capacity, even as Apple expands in-house silicon."
Gemini’s 'insurance policy against export controls' overstates what a 2031 Broadcom tie-up secures. Capacity isn’t the bottleneck; pricing leverage is. A long multi-gen contract can give Broadcom pricing power if memory costs rise or Apple shifts more silicon in-house, anchoring Apple’s cost base for years. The risk isn’t survival of hardware; it’s margin compression from a dependence arc that isn’t offset by the geopolitical angle.
The panel generally agreed that Apple's Broadcom deal secures supply stability and mitigates risk, but the market's 4% reaction may be overstated, and the long-term contract could create pricing leverage for Broadcom. The AI narrative and potential revenue uplift remain unproven.
Supply stability and insurance against potential future export controls on advanced semiconductor manufacturing.
Margin compression due to elevated memory costs and dependence on Broadcom's pricing leverage.